Atossa Therapeutics Inc (ATOS) soared 9.78 in the last month: It’s impossible to believe the numbers

Zack King

Atossa Therapeutics Inc (NASDAQ: ATOS) on Friday, soared 9.78% from the previous trading day, before settling in for the closing price of $0.92. Within the past 52 weeks, ATOS’s price has moved between $0.55 and $1.66.

It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 36.92%. The company achieved an average annual earnings per share of -23.75%. With a float of $129.12 million, this company’s outstanding shares have now reached $129.17 million.

Atossa Therapeutics Inc (ATOS) Insider Updates

Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Atossa Therapeutics Inc is 0.04%, while institutional ownership is 20.93%. The most recent insider transaction that took place on May 21 ’25, was worth 9,887. In this transaction President & CEO of this company bought 11,239 shares at a rate of $0.88, taking the stock ownership to the 13,898 shares. Before that another transaction happened on Mar 26 ’25, when Company’s Director bought 10,000 for $0.70, making the entire transaction worth $7,000. This insider now owns 10,257 shares in total.

Atossa Therapeutics Inc (ATOS) Performance Highlights and Predictions

As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.06 earnings per share (EPS) for the period topping the consensus outlook (set at -0.06) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -23.75% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -15.73% during the next five years compared to 36.92% growth over the previous five years of trading.

Atossa Therapeutics Inc (NASDAQ: ATOS) Trading Performance Indicators

Atossa Therapeutics Inc (ATOS) is currently performing well based on its current performance indicators. A quick ratio of 9.17 was reported for the most recent quarter.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.22, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.28 in one year’s time.

Technical Analysis of Atossa Therapeutics Inc (ATOS)

The latest stats from [Atossa Therapeutics Inc, ATOS] show that its last 5-days average volume of 1.26 million was superior to 0.83 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 87.43%.

During the past 100 days, Atossa Therapeutics Inc’s (ATOS) raw stochastic average was set at 82.34%, which indicates a significant decrease from 83.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0455 in the past 14 days, which was lower than the 0.0465 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.8140, while its 200-day Moving Average is $0.8227. Now, the first resistance to watch is $1.0660. This is followed by the second major resistance level at $1.1219. The third major resistance level sits at $1.1939. If the price goes on to break the first support level at $0.9381, it is likely to go to the next support level at $0.8661. Assuming the price breaks the second support level, the third support level stands at $0.8102.

Atossa Therapeutics Inc (NASDAQ: ATOS) Key Stats

Market capitalization of the company is 130.46 million based on 129,171K outstanding shares. Right now, sales total 0 K and income totals -25,500 K. The company made 0 K in profit during its latest quarter, and -8,420 K in sales during its previous quarter.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.